Abstract
The effect of administration of antibodies against dynorphin 1–17 (DYN 1–17-AB) and dynorphin 1–N(DYN 1–N-AB) were examined on the activity of dopaminergic (DA) neurons comprising the nigrostriatal, mesolimbic, tuberoinfundibular and periventricular-hypophysial systems in the male rat brain. DA neuronal activity was estimated by measuring the concentration of the dopamine metabolite 3,4-dihydrophenylacetic acid (DOPAC) in brain (striatum, nucleus accumbens, median eminence) and pituitary regions (intermediate lobe) containing terminals of these neurons. The intracerebroventricular administration of either DYN 1–17-AB or DYN 1–N-AB produced a time-related increase in the activity of tuberinfundibular and periventricular-hypophysial DA neurons, but failed toalter the activity of nigrstriatal or mesolimbic DA neurons. The ability of both DYN 1–17-AB to endhance of tuberofundibular and periventricular-hypophysial DA neurons was reversed by the kappa opioid ag50,488. These results indicate that 1–17-AB and and DYN 1-N-AB, presumably by binding endogenous dynorphins, remove a tonic inhibitory action of these opioid peptides on tuberoinfundibular and periventricular-hypophysial DA neurons.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.